Core Laboratories (CLB) Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" CLB shares.
View CLB analyst ratings or view top-rated stocks.

3 equities research analysts have issued 12 month price objectives for Core Laboratories' stock. Their CLB share price forecasts range from $20.00 to $25.00. On average, they expect the company's share price to reach $21.88 in the next twelve months. This suggests that the stock has a possible downside of 9.7%.
View analysts price targets for CLB or view top-rated stocks among Wall Street analysts.

Core Laboratories' stock was trading at $20.27 at the start of the year. Since then, CLB shares have increased by 19.5% and is now trading at $24.22.
View the best growth stocks for 2023 here.

Core Laboratories saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 5,580,000 shares, a drop of 19.1% from the August 15th total of 6,900,000 shares. Based on an average trading volume of 512,400 shares, the short-interest ratio is currently 10.9 days. Approximately 12.1% of the company's shares are sold short.
View Core Laboratories' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our CLB earnings forecast.

Core Laboratories Inc. (NYSE:CLB) issued its quarterly earnings data on Wednesday, July, 26th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. The oil and gas company had revenue of $127.88 million for the quarter, compared to analysts' expectations of $132.20 million. Core Laboratories had a net margin of 7.75% and a trailing twelve-month return on equity of 16.83%.

Core Laboratories announced a quarterly dividend on Wednesday, July 26th. Stockholders of record on Monday, August 7th will be paid a dividend of $0.01 per share on Monday, August 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date is Friday, August 4th.
Read our dividend analysis for CLB.

ETFs with the largest weight of Core Laboratories (NYSE:CLB) stock in their portfolio include Cultivar ETF (CVAR), Alger Weatherbie Enduring Growth ETF (AWEG), Invesco S&P SmallCap Energy ETF (PSCE), SPDR S&P Oil & Gas Equipment & Services ETF (XES), iShares U.S. Oil Equipment & Services ETF (IEZ) and VanEck Oil Services ETF (OIH).Direxion Daily Oil Services Bull 2X Shares (ONG).

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.17%. The dividend payout ratio is 4.82%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 4.71% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

Core Laboratories issued an update on its third quarter 2023 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $0.21-$0.25 for the period, compared to the consensus earnings per share estimate of $0.23. The company issued revenue guidance of $128.00 million-$132.00 million, compared to the consensus revenue estimate of $135.99 million.

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by a number of retail and institutional investors. Top institutional investors include Ariel Investments LLC (20.63%), BlackRock Inc. (16.98%), Earnest Partners LLC (8.22%), Boston Trust Walden Corp (4.71%), State Street Corp (3.96%) and Congress Asset Management Co. MA (2.08%).
View institutional ownership trends.

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLB stock can currently be purchased for approximately $24.22.

Core Laboratories (NYSE:CLB) has a market capitalization of $1.13 billion and generates $489.73 million in revenue each year. The oil and gas company earns $19.45 million in net income (profit) each year or $0.83 on an earnings per share basis.

The company employs 3,600 workers across the globe.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (713) 328-2673 or via email at investor.relations@corelab.com.